Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/1996
05/01/1996EP0709099A2 An aqueous nasal suspension comprising cyclodextrin
05/01/1996EP0709087A1 Medicinal and/or nutritional microcapsules for oral administration
05/01/1996EP0708662A1 Injectable polysaccharide-cell compositions
05/01/1996EP0708661A1 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
05/01/1996EP0708660A1 Prodrugs of protein tyrosine kinase inhibitors
05/01/1996EP0708646A1 Use of vitamin e tocopheryl derivatives in ophthalmic compositions
05/01/1996EP0708643A1 Transdermal melatonin delivery system
05/01/1996EP0708637A1 Self-assembling polynucleotide delivery system comprising dendrimer polycations
05/01/1996EP0586694B1 Process and device for low-emission spraying
05/01/1996EP0519926B1 Transdermal system
05/01/1996EP0497956B1 Controlled release formulations
05/01/1996EP0467954B1 Preparation of liposome and lipid complex compositions
05/01/1996EP0441917B1 Pokeweed antiviral protein - monoclonal antibody conjugates
05/01/1996CN1121694A Cyclosporin-containing powder composition
05/01/1996CN1121692A Composition containing cholestyramine and method of producing the same
05/01/1996CN1121691A Stabilized injection and method of stabilizing injection
05/01/1996CN1121688A Stable, ingestable and absorbable NADH and NADPH therapeutic compositions
04/1996
04/30/1996US5512648 Polyamide resin-protide conjugate, preparation and uses
04/30/1996US5512547 Pharmaceutical composition of botulinum neurotoxin and method of preparation
04/30/1996US5512443 Second generation monoclonal antibodies having binding specificity to TAG-72 and human carcinomas and methods for employing the same
04/30/1996US5512329 Substrate surface preparation
04/30/1996US5512306 Smoking substitute
04/30/1996US5512302 Pharmaceutical process using starch
04/30/1996US5512301 Collagen-containing sponges as drug delivery compositions for proteins
04/30/1996US5512297 Sustained release heterodisperse hydrogel systems for insoluble drugs
04/30/1996US5512295 Synthetic liposomes for enhanced uptake and delivery
04/30/1996US5512292 Transdermal contraceptive formulations methods and devices
04/30/1996US5512289 Spermicidal anti-viral lubricant composition and method of using same
04/30/1996US5512278 Ointment base useful for pharmaceutical preparations
04/30/1996US5512270 Respiratory system disorders, parkinson's disease, gastrointestinal disorders
04/30/1996US5512268 Polymeric shells for medical imaging prepared from synthetic polymers, and methods for the use thereof
04/30/1996US5512200 Low pH Acidic Compositions
04/30/1996US5512092 Method for preparing aqueous emulsion for coating solid pharmaceutical preparations
04/30/1996CA2026278C Use of alkylphosphoric acid compounds for combatting psoriasis disorders
04/25/1996WO1996012190A2 Presentation of hydrophobic antigens to t-cells by cd1 molecules
04/25/1996WO1996012019A2 Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family
04/25/1996WO1996011953A1 N-terminally chemically modified protein compositions and methods
04/25/1996WO1996011712A2 Cell-specific gene delivery vehicles
04/25/1996WO1996011711A1 Saponin preparations and use thereof in iscoms
04/25/1996WO1996011710A1 External preparation for nail ringworm
04/25/1996WO1996011706A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation
04/25/1996WO1996011705A1 Formulations comprising therapeutically-active proteins or polypeptides
04/25/1996WO1996011704A1 A pharmaceutical formulation comprising a growth hormone and leucine
04/25/1996WO1996011703A1 A pharmaceutical formulation comprising a growth hormone and isoleucine
04/25/1996WO1996011702A1 A pharmaceutical formulation comprising a growth hormone and valine
04/25/1996WO1996011699A1 Pharmaceutical composition of botulinum neurotoxin and method of preparation
04/25/1996WO1996011694A2 AROMATIC COMPOSITION BASED ON OLIBANAM COMBINED WITH A SYNERGIC AGENT (e.g. EUCALYPTOL, BARNEOL, ZINC, SALT, COPPER, SALT) AND USE THEREOF
04/25/1996WO1996011693A1 Dermatosis remedy
04/25/1996WO1996011687A1 Sabeluzole oral suspensions
04/25/1996WO1996011675A2 Medicinal and/or nutritional microcapsules for per os administration
04/25/1996WO1996011672A1 Lyophilized preparation providing reversibly thermogelling water-base medicinal composition
04/25/1996WO1996011670A1 Ether lipid liposomes and their therapeutic use
04/25/1996WO1996011669A1 Lyophilizate of lipid complex of water insoluble camptothecins
04/25/1996WO1996011667A1 Bifunctional cosmetic and/or dermatological ingredients, uses thereof, preparation method therefor, and compositions containing said ingredients
04/25/1996CA2472085A1 N-terminally chemically modified protein compositions and methods
04/25/1996CA2202680A1 Presentation of hydrophobic antigens to t-cells by cd1 molecules
04/25/1996CA2202622A1 Use of protease inhibitors and protease vaccines to protect animals from flea infestation, and flea protease proteins, nucleic acid molecules and uses thereof
04/25/1996CA2202612A1 Formulations comprising therapeutically-active proteins or polypeptides
04/25/1996CA2202554A1 Aromatic composition on olibanam combined with a synergic agent (e.g. eucalyptol, barneol, zinc, salt, copper, salt) and use thereof
04/25/1996CA2202533A1 Her4 human receptor tyrosine kinase
04/25/1996CA2202478A1 Cell-specific gene delivery vehicles
04/25/1996CA2199179A1 Ether lipid liposomes and their therapeutic use
04/24/1996EP0707857A1 Chitosan oligomer derivatives, labelled with Gd-DTPA, for use as magnetic resonance contrast agents
04/24/1996EP0707853A1 Muscle relaxant pharmaceutical compositions
04/24/1996EP0707848A1 Solid pharmaceutical composition comprising an excipient capable of binding water
04/24/1996EP0707847A1 Ketoprofen liposomes
04/24/1996EP0707846A2 A method for synthesizing a liposome
04/24/1996EP0707596A1 Conjugation-stabilized polypeptide compositions
04/24/1996EP0707489A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
04/24/1996EP0707478A1 Improved nicotine lozenge and therapeutic method for smoking cessation
04/24/1996EP0707475A1 Extended release, film-coated tablet of astemizole and pseudoephedrine
04/24/1996EP0707473A1 Oral pharmaceutical compositions comprising a protein or peptide, an antibody and polymeric beads
04/24/1996EP0707471A1 Novel therapeutic drug delivery systems
04/24/1996EP0707446A1 Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology
04/24/1996EP0662819B1 An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof
04/24/1996EP0649301B1 Cold cream used in oxidative hair dyes and hair bleaching compositions
04/23/1996US5510466 Scavenger receptor protein and antibody thereto
04/23/1996US5510418 Glycosaminoglycan-synthetic polymer conjugates
04/23/1996US5510392 Polyalpha olefins for food and pharmaceutical applications
04/23/1996US5510391 Method of treating blood vessel disorders of the skin using vitamin K
04/23/1996US5510387 Antimicrobial interferon-inducing medicament
04/23/1996US5510327 Containing tumor cytotoxic factor, basic amino acid or salt thereof, organic or inorganic salt
04/23/1996US5510250 Non-reducing oligosaccharide with neotrehalose structure, and its production and uses
04/23/1996US5510240 Method of screening a peptide library
04/23/1996US5510121 Containing a synthetic hydrophilic polymer
04/23/1996US5510103 Physical trapping type polymeric micelle drug preparation
04/22/1996CA2160819A1 Diagnostic imaging agent
04/21/1996CA2160739A1 Ketoprofen liposomes
04/18/1996WO1996011277A1 Microorganisms as therapeutic delivery systems
04/18/1996WO1996011269A2 Tie-2 ligands, methods of making and uses thereof
04/18/1996WO1996011205A1 Peptide nucleic acid conjugates
04/18/1996WO1996011055A1 Method of coating particles
04/18/1996WO1996011054A2 Process for the preparation of microspheres and microspheres made thereby
04/18/1996WO1996011022A1 DRUG COMPOUNDING INGREDIENTS COMPRISING N-SUBSTITUTED-o-TOLUIDINE DERIVATIVE AND PERCUTANEOUSLY ABSORBABLE PREPARATION
04/18/1996WO1996011021A2 Treatment of tissues to reduce subsequent response to injury
04/18/1996WO1996011018A1 Stable, aqueous alfa interferon solution formulations
04/18/1996WO1996011013A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies
04/18/1996WO1996011012A1 Hematopoietic cell l-selectin ligand (hll) and therapeutics thereof
04/18/1996WO1996011008A1 Administration of a 27-hydroxycholesterol or prodrug thereof as an anti-cancer agent
04/18/1996WO1996011007A1 Parenteral pharmaceutical compositions containing gf120918a